U.S. approves Spectrum Pharma’s purchase of Allos

WASHINGTON (Reuters) – U.S. antitrust officials have approved Spectrum Pharmaceuticals’ purchase of cancer drugmaker Allos Therapeutics, a $206 million deal aimed at giving Spectrum access to the Allos anti-cancer drug Folotyn. The Federal Trade Commission posted letters on its web site sent to lawyers for Allos and Spectrum dated August 28 which said it had been investigating the deal but had closed the probe, indicating that the transaction could go forward. Henderson, Nevada-based Spectrum agreed in April to buy Allos for about $1. …

Arkansas conservative group seeks to block medical pot vote

LITTLE ROCK, Arkansas (Reuters) – A conservative Arkansas group seeking to prevent the state from becoming the first in the U.S. South to allow medical marijuana filed a lawsuit on Friday to knock a pot-as-medicine proposal off the November election ballot. The lawsuit filed in the state Supreme Court by the Coalition to Preserve Arkansas Values argues the ballot’s title, the Arkansas Medical Marijuana Act, is misleading and the act itself hard to understand at 8,000 words long. …

1 2 3 106